Vicente LLP Federal and International Cannabis and Psychedelics Law and Policy Update: November 2023
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
Archive
Top Five Countries to Watch for International Cannabis Reform in 2024
By Jason Adelstone
Nov 6, 2023
While the cannabis industry in the United States awaits a marijuana scheduling decision from the DEA, many countries around the world continue to move forward with liberalizing their cannabis policies as a superior method of promoting the health and welfare of their citizens. In this blog post, we’ll take a closer look at five countries poised to make waves in the cannabis landscape in 2024, including Germany, Thailand, Colombia, the Czech Republic, and Switzerland.
[Webinar] Identifying International Cannabis Opportunities in Europe
Oct 26, 2023
This recorded session features members of Vicente LLP’s Federal and International Law and Policy practice group and London cannabis attorney Robert Jappie of Fieldfisher sharing insights into what’s happening with cannabis and hemp-derived cannabinoids across the pond and opportunities for US operators and investors.
CBD Products Liability Lawsuits Could Be Revived After FDA Declines to Regulate Cannabidiol
By Catie Wightman
Feb 13, 2023
In recent years, several CBD companies faced product liability lawsuits brought by consumers. Many of these cases were dismissed without prejudice or stayed until the FDA takes action to regulate CBD products. Now that the FDA said it will not take action to regulate CBD, could these cases be revived?
Recommending CBD and Hemp Products for Pets: Legal Considerations for Veterinarians
By Catie Wightman
Feb 9, 2023
With recent announcements from the FDA pushing CBD and hemp-derived products further into a legal gray area, can veterinarians recommend or sell these products for pets?
10 Key Takeaways from the Colorado Intoxicating Hemp Task Force Final Report
By Catie Wightman
Jan 17, 2023
The SB 22-205 Intoxicating Hemp Task Force's final report makes legislative and rule recommendations concerning the regulation of intoxicating and synthetic hemp products in Colorado. We compiled 10 key takeaways for hemp industry stakeholders.
Recommending Cannabis for Pets: Legal Considerations for Veterinarians
By Catie Wightman
Jan 3, 2023
In this two-part VS Insights series, we discuss the potential legal implications for veterinarians to consider regarding cannabis and hemp products. This first article focuses on cannabis products, while part two focuses on hemp and hemp-derived products.
[Webinar] Intoxicating Hemp Regulations: Where We Are and What's to Come
Dec 15, 2022
Watch as Vicente Sederberg LLP and EARTH Law LLC discuss the regulatory approaches for intoxicating hemp in Colorado, Oregon and California, and our projections for the future
Recent FDA Enforcement Letters Signal Increased FDA Scrutiny of Hemp Products
By Catie Wightman, Michelle Bodian
Nov 30, 2022
On November 21, 2022, the FDA issued five warning letters to companies selling CBD, Delta-8, and other hemp products for humans and pets.
Guide for Shipping Hemp and Hemp-Derived CBD Products
By Michelle Bodian, Catie Wightman
Nov 1, 2022
Planning to ship hemp or hemp-derived CBD products? Read this first.
Lessons Learned from the Regulation of CBD Products in the United Kingdom
By Shawn Hauser, Catie Wightman, Ariane Beckman
Sep 20, 2022
Like the US, regulators in the UK are struggling to find ways to best regulate CBD and other hemp-derived products—frustrating hemp businesses across the globe. Read this VS Insights article to learn how the UK is currently regulating CBD and key findings and recommendations from the ACMD's Consumer CBD Products Report.
FDA Enforcement Continues Against Companies Making CBD Product Claims
By Catie Wightman, Ariane Beckman
Aug 11, 2022
The FDA is cracking down on companies making unlawful drug or disease claims about their products relating to CBD by recently issuing several warning letters to address these compliance violations.
Key Takeaways from Intoxicating Cannabinoids: The Science and the Law Webinar
By Catie Wightman, Shawn Hauser
Jun 16, 2022
We recently hosted a webinar exploring intoxicating hemp-derived products. Read this for key takeaways from the session.
FDA Enforcement Action Targeted at Hemp-Derived Delta-8 Products
By Michelle Bodian, Shawn Hauser, Catie Wightman
May 5, 2022
For the first time ever, the FDA issued warning letters to companies selling products containing hemp-derived Delta-8 THC. Notably, this is the first time the FDA has specifically enforced against Delta-8 products. Read this for key takeaways from these warning letters.
[Webinar] Minor Cannabinoids & Trending Topics in Hemp
Apr 1, 2022
Watch this session exploring trending topics in hemp. During the session, members of our hemp team dive into the legality, regulation, and lawsuits surrounding minor cannabinoids, current federal hemp legislation, and what we expect and hope to see in the 2023 Farm Bill.
2014 Farm Bill Expiration: What Does it Mean for State Hemp Programs?
By Michelle Bodian, Catie Wightman
Dec 17, 2021
After several extensions, the 2014 Farm Bill is finally set to expire on Dec. 31. What's next for state hemp programs and what are the 2018 Farm Bill's notable requirements?
[Webinar] Spotlight on Colorado's Cannabis Market
Oct 19, 2021
Watch this recorded session for an update on recent changes in the Colorado market from members of our Colorado regulatory, corporate, and hemp teams and special guest Christopher Stefan of Cannabis Capital Advisors.
NAACP to Host Free Expungement Clinic with The Color of Cannabis and Vicente Sederberg LLP
Jul 22, 2021
VS's Jason Adelstone, Catie Wightman and Genevieve Meehan will participate in a free expungement clinic to be held on July 31, 2021 in Denver.
Federal and State Overview: Regulation of Products Containing 'Minor' Hemp-Derived Cannabinoids
By Catie Wightman, Jace Pohlman
Jul 13, 2021
Move over CBD; there are new cannabinoids in town. CBD has been the most sought-after and utilized hemp-derived cannabinoid in consumer products, but due in part to technological advances, various other hemp-derived cannabinoids, like CBG, CBN, and CBC, are now creating a well-deserved buzz.
New Hemp CBD Laws, Regulations, and Policies: June 2021 Update
By Caitlin Wightman, Michelle Bodian, Jace Pohlman
Jun 15, 2021
Over the first half of 2021, many states passed laws, implemented, or proposed new regulations regarding hemp cultivation, processing, and CBD products. These changes range from updates to testing, labeling, and packaging requirements, to adjustments in license requirements and limits on the types of hemp-derived products that can be sold.
Seven Regulatory-related Factors for Marijuana Companies to Consider in a Debt Transaction
By Charles Alovisetti
Jan 25, 2021
Like anything in the cannabis industry, getting a debt deal done requires navigating unique regulatory challenges. Here are seven regulatory considerations that cannabis borrowers and lenders should keep in mind when pursuing a debt transaction.
5 Key Takeaways from the FTC CBDeceit Crackdown on CBD Businesses
By Caitlin Wightman, Michelle Bodian
Dec 23, 2020
On December 17, 2020, the Federal Trade Commission announced robust enforcement actions against companies making deceptive claims about CBD and CBG products.
Vicente Sederberg LLP Hemp Update: November 2020
Nov 25, 2020
Update on hemp legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
Selling CBD Products Online? State Retailer Registration Requirements May Apply
By Catie Wightman
Nov 16, 2020
If you are selling CBD products—even products sold exclusively online—you must follow retailer requirements in the states where you sell products (i.e., where your customers are located).
Raising Private Capital in the Cannabis Industry
By Charles Alovisetti, Elliot Choi, Sahar Ayinehsazian
Sep 18, 2020
Raising private capital continues to be a challenge for the nascent cannabis industry, but there are proactive steps companies can take to maximize the chance of a successful raise.